APO Research
Talk to an analyst

APO RESEARCH · REPORT

Solifenacin Succinate Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Solifenacin Succinate Drug Industry Growth and Trends Forecast to 2032

22 December 2025105 pages

Choose your research edition.

Industry ResearchSolifenacin Succinate Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Solifenacin Succinate Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Solifenacin Succinate Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Solifenacin Succinate Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Solifenacin Succinate Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Solifenacin Succinate Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Solifenacin Succinate Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Solifenacin Succinate Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Solifenacin Succinate Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Solifenacin Succinate Drug include Teva, Qilu Pharmaceutical, Jiangxi Boya Seehot Pharmaceutical, Astellas Pharma, VESICARE, Glenmark Pharmaceuticals, Crescent Pharma, Cipla and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Solifenacin Succinate Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Solifenacin Succinate Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Solifenacin Succinate Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Solifenacin Succinate Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Solifenacin Succinate Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Solifenacin Succinate Drug Market by Company

Teva

Qilu Pharmaceutical

Jiangxi Boya Seehot Pharmaceutical

Astellas Pharma

VESICARE

Glenmark Pharmaceuticals

Crescent Pharma

Cipla

Aurobindo Pharma

Ajanta Pharma

Solifenacin Succinate Drug Segment by Type

5 mg Tablet

10 mg Tablet

Solifenacin Succinate Drug Segment by Application

Hospital

Drug store

Solifenacin Succinate Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solifenacin Succinate Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Solifenacin Succinate Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solifenacin Succinate Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Solifenacin Succinate Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Solifenacin Succinate Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 mg Tablet Table 2. Major Company of 10 mg Tablet Table 3. Global Solifenacin Succinate Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 5. Global Solifenacin Succinate Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Solifenacin Succinate Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Solifenacin Succinate Drug Price by Type (2021-2026) & (US$/unit) Table 9. Global Solifenacin Succinate Drug Sales by Type (2027-2032) & (k units) Table 10. Global Solifenacin Succinate Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Solifenacin Succinate Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Solifenacin Succinate Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Solifenacin Succinate Drug Price by Type (2027-2032) & (US$/unit) Table 14. North America Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 15. North America Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 17. Europe Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 21. Latin America Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Solifenacin Succinate Drug Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Solifenacin Succinate Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Solifenacin Succinate Drug Industry Trends Table 25. Solifenacin Succinate Drug Industry Drivers Table 26. Solifenacin Succinate Drug Industry Opportunities and Challenges Table 27. Solifenacin Succinate Drug Industry Restraints Table 28. Global Solifenacin Succinate Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Solifenacin Succinate Drug Revenue Market Share by Company (2021-2026) Table 30. Global Solifenacin Succinate Drug Sales by Company (2021-2026) & (k units) Table 31. Global Solifenacin Succinate Drug Sales Share by Company (2021-2026) Table 32. Global Solifenacin Succinate Drug Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Solifenacin Succinate Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Solifenacin Succinate Drug Major Company Production Sites and Headquarters Table 35. Global Solifenacin Succinate Drug Company, Product Type & Application Table 36. Global Solifenacin Succinate Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Solifenacin Succinate Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Solifenacin Succinate Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Solifenacin Succinate Drug Sales by Region (2021-2026) & (k units) Table 41. Global Solifenacin Succinate Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Solifenacin Succinate Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Solifenacin Succinate Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Solifenacin Succinate Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Solifenacin Succinate Drug Sales by Region (2027-2032) & (k units) Table 46. Global Solifenacin Succinate Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Solifenacin Succinate Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Solifenacin Succinate Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Solifenacin Succinate Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Solifenacin Succinate Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 52. Global Solifenacin Succinate Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Solifenacin Succinate Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Solifenacin Succinate Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global Solifenacin Succinate Drug Sales by Application (2027-2032) & (k units) Table 57. Global Solifenacin Succinate Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Solifenacin Succinate Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Solifenacin Succinate Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Solifenacin Succinate Drug Price by Application (2027-2032) & (US$/unit) Table 61. North America Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 62. North America Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 64. Europe Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 68. Latin America Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Solifenacin Succinate Drug Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Solifenacin Succinate Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Solifenacin Succinate Drug Product Portfolio Table 75. Teva Recent Development Table 76. Qilu Pharmaceutical Company Information Table 77. Qilu Pharmaceutical Business Overview Table 78. Qilu Pharmaceutical Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Qilu Pharmaceutical Solifenacin Succinate Drug Product Portfolio Table 80. Qilu Pharmaceutical Recent Development Table 81. Jiangxi Boya Seehot Pharmaceutical Company Information Table 82. Jiangxi Boya Seehot Pharmaceutical Business Overview Table 83. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product Portfolio Table 85. Jiangxi Boya Seehot Pharmaceutical Recent Development Table 86. Astellas Pharma Company Information Table 87. Astellas Pharma Business Overview Table 88. Astellas Pharma Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Astellas Pharma Solifenacin Succinate Drug Product Portfolio Table 90. Astellas Pharma Recent Development Table 91. VESICARE Company Information Table 92. VESICARE Business Overview Table 93. VESICARE Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. VESICARE Solifenacin Succinate Drug Product Portfolio Table 95. VESICARE Recent Development Table 96. Glenmark Pharmaceuticals Company Information Table 97. Glenmark Pharmaceuticals Business Overview Table 98. Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Glenmark Pharmaceuticals Solifenacin Succinate Drug Product Portfolio Table 100. Glenmark Pharmaceuticals Recent Development Table 101. Crescent Pharma Company Information Table 102. Crescent Pharma Business Overview Table 103. Crescent Pharma Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Crescent Pharma Solifenacin Succinate Drug Product Portfolio Table 105. Crescent Pharma Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Cipla Solifenacin Succinate Drug Product Portfolio Table 110. Cipla Recent Development Table 111. Aurobindo Pharma Company Information Table 112. Aurobindo Pharma Business Overview Table 113. Aurobindo Pharma Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Aurobindo Pharma Solifenacin Succinate Drug Product Portfolio Table 115. Aurobindo Pharma Recent Development Table 116. Ajanta Pharma Company Information Table 117. Ajanta Pharma Business Overview Table 118. Ajanta Pharma Solifenacin Succinate Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Ajanta Pharma Solifenacin Succinate Drug Product Portfolio Table 120. Ajanta Pharma Recent Development Table 121. North America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Solifenacin Succinate Drug Sales by Country (2021-2026) & (k units) Table 123. North America Solifenacin Succinate Drug Sales Market Share by Country (2021-2026) Table 124. North America Solifenacin Succinate Drug Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Solifenacin Succinate Drug Sales Market Share Forecast by Country (2027-2032) Table 126. North America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Solifenacin Succinate Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Solifenacin Succinate Drug Market Share by Country (2021-2026) Table 129. North America Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Solifenacin Succinate Drug Market Share Forecast by Country (2027-2032) Table 131. Europe Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Solifenacin Succinate Drug Sales by Country (2021-2026) & (k units) Table 133. Europe Solifenacin Succinate Drug Sales Market Share by Country (2021-2026) Table 134. Europe Solifenacin Succinate Drug Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Solifenacin Succinate Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Solifenacin Succinate Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Solifenacin Succinate Drug Market Share by Country (2021-2026) Table 139. Europe Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Solifenacin Succinate Drug Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Solifenacin Succinate Drug Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Solifenacin Succinate Drug Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Solifenacin Succinate Drug Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Solifenacin Succinate Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Solifenacin Succinate Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Solifenacin Succinate Drug Market Share by Country (2021-2026) Table 149. Asia-Pacific Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Solifenacin Succinate Drug Market Share Forecast by Country (2027-2032) Table 151. Latin America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Solifenacin Succinate Drug Sales by Country (2021-2026) & (k units) Table 153. Latin America Solifenacin Succinate Drug Sales Market Share by Country (2021-2026) Table 154. Latin America Solifenacin Succinate Drug Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Solifenacin Succinate Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Solifenacin Succinate Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Solifenacin Succinate Drug Market Share by Country (2021-2026) Table 159. Latin America Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Solifenacin Succinate Drug Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Solifenacin Succinate Drug Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Solifenacin Succinate Drug Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Solifenacin Succinate Drug Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Solifenacin Succinate Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Solifenacin Succinate Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Solifenacin Succinate Drug Market Share by Country (2021-2026) Table 169. Middle East and Africa Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Solifenacin Succinate Drug Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Solifenacin Succinate Drug Distributors List Table 174. Solifenacin Succinate Drug Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Solifenacin Succinate Drug Image Figure 2. Global Solifenacin Succinate Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Solifenacin Succinate Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Solifenacin Succinate Drug Sales (2021-2032) & (k units) Figure 5. 5 mg Tablet Image Figure 6. Global 5 mg Tablet Sales YoY Growth (2021-2032) & (k units) Figure 7. 10 mg Tablet Image Figure 8. Global 10 mg Tablet Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Solifenacin Succinate Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Solifenacin Succinate Drug Market Share by Type 2025 VS 2032 Figure 11. North America Solifenacin Succinate Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Solifenacin Succinate Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Solifenacin Succinate Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Solifenacin Succinate Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Solifenacin Succinate Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Solifenacin Succinate Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Solifenacin Succinate Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Solifenacin Succinate Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Solifenacin Succinate Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Solifenacin Succinate Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Solifenacin Succinate Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Drug store Image Figure 26. Global Drug store Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Solifenacin Succinate Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Solifenacin Succinate Drug Market Share by Application 2025 VS 2032 Figure 29. North America Solifenacin Succinate Drug Sales Market Share in Volume by Application in 2025 Figure 30. North America Solifenacin Succinate Drug Sales Market Share in Value by Application in 2025 Figure 31. Europe Solifenacin Succinate Drug Sales Market Share in Volume by Application in 2025 Figure 32. Europe Solifenacin Succinate Drug Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Solifenacin Succinate Drug Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Solifenacin Succinate Drug Sales Market Share in Value by Application in 2025 Figure 35. Latin America Solifenacin Succinate Drug Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Solifenacin Succinate Drug Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Solifenacin Succinate Drug Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Solifenacin Succinate Drug Sales Market Share in Value by Application in 2025 Figure 39. North America Solifenacin Succinate Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Solifenacin Succinate Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Solifenacin Succinate Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Solifenacin Succinate Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Solifenacin Succinate Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Solifenacin Succinate Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Solifenacin Succinate Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Solifenacin Succinate Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Solifenacin Succinate Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Solifenacin Succinate Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Solifenacin Succinate Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Solifenacin Succinate Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Solifenacin Succinate Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Solifenacin Succinate Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Solifenacin Succinate Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Solifenacin Succinate Drug Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Solifenacin Succinate Drug Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Tablet
  • 10 mg Tablet
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Qilu Pharmaceutical
  • Jiangxi Boya Seehot Pharmaceutical
  • Astellas Pharma
  • VESICARE
  • Glenmark Pharmaceuticals
  • Crescent Pharma
  • Cipla
  • Aurobindo Pharma
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Solifenacin Succinate Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Solifenacin Succinate Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Solifenacin Succinate Drug Market by Type
  6. 1.3.1 5 mg Tablet
  7. 1.3.2 10 mg Tablet
  8. 1.4 Global Solifenacin Succinate Drug Market Size by Type
  9. 1.4.1 Global Solifenacin Succinate Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Solifenacin Succinate Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Solifenacin Succinate Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Solifenacin Succinate Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Solifenacin Succinate Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Solifenacin Succinate Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Solifenacin Succinate Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Solifenacin Succinate Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Solifenacin Succinate Drug Industry Trends
  2. 2.2 Solifenacin Succinate Drug Industry Drivers
  3. 2.3 Solifenacin Succinate Drug Industry Opportunities and Challenges
  4. 2.4 Solifenacin Succinate Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Solifenacin Succinate Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Solifenacin Succinate Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Solifenacin Succinate Drug Price (2021-2026)
  4. 3.4 Global Solifenacin Succinate Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Solifenacin Succinate Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Solifenacin Succinate Drug Company, Product Type & Application
  7. 3.7 Global Solifenacin Succinate Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Solifenacin Succinate Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Solifenacin Succinate Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Solifenacin Succinate Drug Tier 1, Tier 2, and Tier 3
4 Solifenacin Succinate Drug Regional Status and Outlook
  1. 4.1 Global Solifenacin Succinate Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Solifenacin Succinate Drug Historic Market Size by Region
  3. 4.2.1 Global Solifenacin Succinate Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Solifenacin Succinate Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Solifenacin Succinate Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Solifenacin Succinate Drug Forecasted Market Size by Region
  7. 4.3.1 Global Solifenacin Succinate Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Solifenacin Succinate Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Solifenacin Succinate Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Solifenacin Succinate Drug by Application
  1. 5.1 Solifenacin Succinate Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Solifenacin Succinate Drug Market Size by Application
  5. 5.2.1 Global Solifenacin Succinate Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Solifenacin Succinate Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Solifenacin Succinate Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Solifenacin Succinate Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Solifenacin Succinate Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Solifenacin Succinate Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Solifenacin Succinate Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Solifenacin Succinate Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Solifenacin Succinate Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Solifenacin Succinate Drug Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Jiangxi Boya Seehot Pharmaceutical
  14. 6.3.1 Jiangxi Boya Seehot Pharmaceutical Company Information
  15. 6.3.2 Jiangxi Boya Seehot Pharmaceutical Business Overview
  16. 6.3.3 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product Portfolio
  18. 6.3.5 Jiangxi Boya Seehot Pharmaceutical Recent Developments
  19. 6.4 Astellas Pharma
  20. 6.4.1 Astellas Pharma Company Information
  21. 6.4.2 Astellas Pharma Business Overview
  22. 6.4.3 Astellas Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Astellas Pharma Solifenacin Succinate Drug Product Portfolio
  24. 6.4.5 Astellas Pharma Recent Developments
  25. 6.5 VESICARE
  26. 6.5.1 VESICARE Company Information
  27. 6.5.2 VESICARE Business Overview
  28. 6.5.3 VESICARE Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 VESICARE Solifenacin Succinate Drug Product Portfolio
  30. 6.5.5 VESICARE Recent Developments
  31. 6.6 Glenmark Pharmaceuticals
  32. 6.6.1 Glenmark Pharmaceuticals Company Information
  33. 6.6.2 Glenmark Pharmaceuticals Business Overview
  34. 6.6.3 Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Glenmark Pharmaceuticals Solifenacin Succinate Drug Product Portfolio
  36. 6.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 6.7 Crescent Pharma
  38. 6.7.1 Crescent Pharma Company Information
  39. 6.7.2 Crescent Pharma Business Overview
  40. 6.7.3 Crescent Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Crescent Pharma Solifenacin Succinate Drug Product Portfolio
  42. 6.7.5 Crescent Pharma Recent Developments
  43. 6.8 Cipla
  44. 6.8.1 Cipla Company Information
  45. 6.8.2 Cipla Business Overview
  46. 6.8.3 Cipla Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Solifenacin Succinate Drug Product Portfolio
  48. 6.8.5 Cipla Recent Developments
  49. 6.9 Aurobindo Pharma
  50. 6.9.1 Aurobindo Pharma Company Information
  51. 6.9.2 Aurobindo Pharma Business Overview
  52. 6.9.3 Aurobindo Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aurobindo Pharma Solifenacin Succinate Drug Product Portfolio
  54. 6.9.5 Aurobindo Pharma Recent Developments
  55. 6.10 Ajanta Pharma
  56. 6.10.1 Ajanta Pharma Company Information
  57. 6.10.2 Ajanta Pharma Business Overview
  58. 6.10.3 Ajanta Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ajanta Pharma Solifenacin Succinate Drug Product Portfolio
  60. 6.10.5 Ajanta Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Solifenacin Succinate Drug Sales by Country
  2. 7.1.1 North America Solifenacin Succinate Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Solifenacin Succinate Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Solifenacin Succinate Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Solifenacin Succinate Drug Market Size by Country
  6. 7.2.1 North America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Solifenacin Succinate Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Solifenacin Succinate Drug Sales by Country
  2. 8.1.1 Europe Solifenacin Succinate Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Solifenacin Succinate Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Solifenacin Succinate Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Solifenacin Succinate Drug Market Size by Country
  6. 8.2.1 Europe Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Solifenacin Succinate Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Solifenacin Succinate Drug Sales by Country
  2. 9.1.1 Asia-Pacific Solifenacin Succinate Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Solifenacin Succinate Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Solifenacin Succinate Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Solifenacin Succinate Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Solifenacin Succinate Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Solifenacin Succinate Drug Sales by Country
  2. 10.1.1 South America Solifenacin Succinate Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Solifenacin Succinate Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Solifenacin Succinate Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Solifenacin Succinate Drug Market Size by Country
  6. 10.2.1 South America Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Solifenacin Succinate Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Solifenacin Succinate Drug Sales by Country
  2. 11.1.1 Middle East and Africa Solifenacin Succinate Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Solifenacin Succinate Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Solifenacin Succinate Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Solifenacin Succinate Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Solifenacin Succinate Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Solifenacin Succinate Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Solifenacin Succinate Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Solifenacin Succinate Drug Value Chain Analysis
  2. 12.1.1 Solifenacin Succinate Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Solifenacin Succinate Drug Production Mode & Process
  7. 12.2 Solifenacin Succinate Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Solifenacin Succinate Drug Distributors
  10. 12.2.3 Solifenacin Succinate Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst